Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neil is a personalized health and telehealth company that leverages advanced diagnostics, including microbiome and metabolic testing, to provide tailored medical treatments and wellness plans. The company specializes in weight management and metabolic health, offering access to GLP-1 receptor agonists and other pharmaceutical interventions through a digital-first platform. By integrating clinical data with individual biological markers, Neil aims to optimize patient outcomes through precision medicine and continuous remote monitoring. Their services include physician consultations, personalized nutrition guidance, and prescription delivery, positioning them as a comprehensive solution for chronic metabolic conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neil.